Christensen Jamie's Form 4 filing
Mirati Therapeutics, Inc. (MRTX) · filed Dec 7, 2021
- Accession no.
- 0001214659-21-012820
- Filed
- Dec 7, 2021
- Trade date
- Dec 3-6, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $157.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Christensen JamieCIK 0001599324 | Officer (EVP, Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2021 | Common Stock | AGrant or awardAcquired | +6,856 | $0.00 | $0 | 60,706 | Direct | |
| Dec 6, 2021 | Common Stock | SSaleDisposed | −1,192 | $130.78 | −$155,889.76 | 59,514 | Direct | |
| Dec 6, 2021 | Common Stock | SSaleDisposed | −9 | $132.00 | −$1,188 | 59,505 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.